🇺🇸 FDA
Pipeline program

Tadalafil

YAN2024-1201

Unknown small_molecule active

Quick answer

Tadalafil for Pulmonary Arterial Hypertension (PAH) is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Pulmonary Arterial Hypertension (PAH)
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials